Arkolith/Insider Trading/ENTA/Form 4

Luu Brendan

Chief Business OfficerENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Dec 10, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2024Sell(S)2K$8.06$18K36K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-24-020384) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML